Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ 51.9 Cr.
- Current Price ₹ 44.9
- High / Low ₹ 69.7 / 35.7
- Stock P/E 7.17
- Book Value ₹ 37.0
- Dividend Yield 0.73 %
- ROCE 24.5 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 146% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%
Cons
- Promoter holding has decreased over last quarter: -2.65%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.66 | |
27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.02 | 40.59 | |
Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.91 | 10.07 |
OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.31% | 19.88% |
0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.97 | -0.12 | 0.01 | |
Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.13 |
Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.27 |
Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 9.68 |
Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | 25.21% |
0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 7.24 | |
EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 19% |
TTM: | 27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 146% |
3 Years: | 52% |
TTM: | 15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -7% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 26% |
Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 |
Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 |
2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.57 | 1.04 | |
1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.52 | 4.58 | |
Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 5.96 | |
CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.68 |
8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.70 | |
Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
Cash Flows
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.85 | 5.48 | ||
0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.54 | -7.13 | ||
0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | 0.03 | ||
Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 |
Ratios
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 | 68.23 |
Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 | 127.15 |
Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 |
Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 | 183.06 |
Working Capital Days | 91.35 | 59.59 | 57.05 | 74.85 | 72.49 | 134.69 | 212.07 | 182.57 |
ROCE % | 0.68% | 1.12% | 35.91% | 63.26% | 32.85% | 24.48% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
4h - Newspaper Advertisement for upcoming Extra Ordinary General Meeting
-
Submission Of Notice Of 01/2025-26 Extra-Ordinary General Meeting - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
1d - EGM on July 23, 2025, for preferential issue of 91.02 lakh warrants worth INR 38.46 crore.
-
Convening Of 01/2025-26 Extra-Ordinary General Meeting ('EGM') On Wednesday, 23Rd July, 2025 At 10:00 A.M At The Registered Office Of The Company. The Notice Of The Said EGM And Other Related Details Shall Be Submitted To The Stock Exchanges In Due Course In Compliance With The Provisions Of The SEBI Listing Regulations
26 Jun - Shelter Pharma to raise INR 38.46 Cr via 91.02 lakh convertible warrants at INR 42.25 each; EGM on July 23, 2025.
- Fixed Thursday, 17Th July, 2025 As The Record Date For The Purpose Of Determining The Eligibility Of The Members To Attend And Vote (Including Through E-Voting) At The 01/2025-26 Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On Wednesday, 23Rd July, 2025. 26 Jun
-
Announcement under Regulation 30 (LODR)-Preferential Issue
26 Jun - Shelter Pharma to raise INR 38.46 Cr via preferential convertible warrants to promoters and others.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals